Abbisko Cayman (STU:8ZD) FCF Yield % : -23.49 (As of May. 26, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Abbisko Cayman's Trailing 12-Month Free Cash Flow is €-58.80 Mil, and Market Cap is €252.02 Mil. Therefore, Abbisko Cayman's FCF Yield % for today is -23.49%.

The historical rank and industry rank for Abbisko Cayman's FCF Yield % or its related term are showing as below:

STU:8ZD' s FCF Yield % Range Over the Past 10 Years
Min: -39.88 Med: -27.6 Max: -10.43
Current: -23.49

During the past 5 years, the highest FCF Yield % of Abbisko Cayman was -10.43%. The lowest was -39.88%. And the median was -27.60%.

STU:8ZD's FCF Yield % is ranked worse than
61.24% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs STU:8ZD: -23.49

Abbisko Cayman's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Abbisko Cayman FCF Yield % Historical Data

The historical data trend for Abbisko Cayman's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman FCF Yield % Chart

Abbisko Cayman Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-21.78

-21.99

Abbisko Cayman Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-14.40	-27.47	-30.61	-21.18

Competitive Comparison of Abbisko Cayman's FCF Yield %

For the Biotechnology subindustry, Abbisko Cayman's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbisko Cayman's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abbisko Cayman's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Abbisko Cayman's FCF Yield % falls into.

Abbisko Cayman FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Abbisko Cayman's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-58.688	/	266.917496
	=	-21.99%

Abbisko Cayman's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-28.26	*	2	/	266.917496
	=	-21.18%

Abbisko Cayman FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Abbisko Cayman FCF Yield % Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbisko Cayman (STU:8ZD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

02256:Hong Kong

Address

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

https://www.abbisko.com

Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (STU:8ZD) Headlines

No Headlines